T.Rx Capital
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://www.trxcap.com
- HQ
- MA
T.Rx Capital is a venture firm with co-founding managing partners Kwesi Frimpong-Boateng and Michael Langer, and Robert Langer serves as Executive Chairman and Chair of its Scientific Advisory Board. Liz Kwo is a venture partner. The firm's portfolio includes Recuro, a digital health solutions company focused on virtual care, and Zus, a shared health data platform for healthcare data interoperability.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Seed, Series A, Series B | Not enough dated deals |
| Sectors | Healthtech, Biotech | Not enough dated deals |
| Regions | Global | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| T.Rx Capital Fund I, LP | 2024 | $77.2M to $175M (Form D) | Open, writing first checks |
03 · People across funds
- Kwesi Frimpong-Boateng, Co-founder & Managing Partner
T.Rx Capital Fund I, LP (Named on Form D)
- Michael Langer, Co-founder & Managing Partner
T.Rx Capital Fund I, LP (Named on Form D)
- Anita DiFazio, Director of Finance and Accounting
T.Rx Capital Fund I, LP (Team)
- Liz Kwo, Venture Partner
T.Rx Capital Fund I, LP (Team)
- Robert Langer, Executive Chairman & Chair of Scientific Advisory Board
T.Rx Capital Fund I, LP (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://www.trxcap.com
- https://www.trxcap.com/contact
- https://www.trxcap.com/
- https://www.trxcap.com/posts/t-rx-capital-launches-77-5m-fund-i-to-invest-in-bold-startups-at-the-intersection-of-technology-and-biology
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026